Literature DB >> 30809474

Th lymphocyte subsets in patients with Vogt-Koyanagi-Harada disease.

Liang Liang1,2, Xiao-Yan Peng2, Hong Wang2.   

Abstract

AIM: To assess helper T (Th) lymphocyte subset balance in patients with Vogt-Koyanagi-Harada (VKH) disease.
METHODS: Sixty-eight active VKH patients and seventy-two inactive VKH patients were included in this study. One hundred healthy individuals served as controls. Peripheral blood was obtained from VKH patients and healthy controls. Th lymphocyte subsets were analyzed by flow cytometry. Plasma concentration of interleukin (IL)-17, IL-10, transforming growth factor (TGF)-β, IL-23 and IL-6 was examined by enzyme-linked immunosorbent assay (ELISA).
RESULTS: VKH patients with active uveitis had significantly higher percentages of both Th1 and Th17 cells and lower percentages of regulatory T (Treg) cells as compared with inactive VKH patients and healthy controls. Th1/Th2 and Th17/Treg ratios were also significantly elevated in active VKH patients. The percentages of Th1, Th17 and Treg cells and the Th1/Th2, Th17/Treg ratio did not differ between inactive VKH patients and healthy controls. There was no difference concerning the percentage of Th2 cells among all the groups. VKH patients with active uveitis showed an elevated level of peripheral Th17 related cytokines levels (TGF-β, IL-6, IL-23, and IL-17) and a decreased level of Treg related cytokines (IL-10) compared with inactive VKH patients and healthy controls. Inactive VKH patients showed no differences in peripheral Th17 related cytokines (TGF-β, IL-6, IL-23, and IL-17) and Treg related cytokines (IL-10) levels compared with healthy controls.
CONCLUSION: Th1 and Th17 cells are significantly increased and Treg cells significantly decreased in active VKH compared with inactive VKH or healthy controls. Therefore, Th lymphocyte subset analysis may serve as a disease biomarker for VKH.

Entities:  

Keywords:  Th lymphocyte; Th17 cell; Treg cell; Vogt-Koyanagi-Harada disease; cytokines

Year:  2019        PMID: 30809474      PMCID: PMC6376230          DOI: 10.18240/ijo.2019.02.04

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  8 in total

1.  Tregs in Autoimmune Uveitis.

Authors:  Zhaohao Huang; Wenli Li; Wenru Su
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.

Authors:  Quan Zhang; Xing Fan; Meng Tian; Hongling Han
Journal:  BMC Nephrol       Date:  2020-07-13       Impact factor: 2.388

3.  Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population.

Authors:  Takuto Sakono; Akira Meguro; Masaki Takeuchi; Takahiro Yamane; Takeshi Teshigawara; Nobuyoshi Kitaichi; Yukihiro Horie; Kenichi Namba; Shigeaki Ohno; Kumiko Nakao; Taiji Sakamoto; Tsutomu Sakai; Tadashi Nakano; Hiroshi Keino; Annabelle A Okada; Atsunobu Takeda; Takako Ito; Hisashi Mashimo; Nobuyuki Ohguro; Shinichirou Oono; Hiroshi Enaida; Satoshi Okinami; Nobuyuki Horita; Masao Ota; Nobuhisa Mizuki
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

Review 4.  Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis.

Authors:  Kailei Guo; Xiaomin Zhang
Journal:  J Immunol Res       Date:  2021-03-16       Impact factor: 4.818

5.  Serum Metabolomic Profiling of Patients with Non-Infectious Uveitis.

Authors:  Hiroyuki Shimizu; Yoshihiko Usui; Masaki Asakage; Naoya Nezu; Ryo Wakita; Kinya Tsubota; Masahiro Sugimoto; Hiroshi Goto
Journal:  J Clin Med       Date:  2020-12-06       Impact factor: 4.241

6.  Integrated Analysis of Key Pathways and Drug Targets Associated With Vogt-Koyanagi-Harada Disease.

Authors:  Zhijun Chen; Zhenyu Zhong; Wanyun Zhang; Guannan Su; Peizeng Yang
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

Review 7.  Vogt-Koyanagi-Harada disease: the step-by-step approach to a better understanding of clinicopathology, immunopathology, diagnosis, and management: a brief review.

Authors:  Cristhian A Urzua; Carl P Herbort; Masaru Takeuchi; Ariel Schlaen; Luz E Concha-Del-Rio; Yoshihiko Usui; Loreto Cuitino; Ioannis Papasavvas
Journal:  J Ophthalmic Inflamm Infect       Date:  2022-05-12

8.  Case report: Bilateral panuveitis resembling Vogt-Koyanagi-Harada disease after second dose of BNT162b2 mRNA COVID-19 vaccine.

Authors:  Tomohito Sato; Ryotaro Nihei; Daisuke Sora; Yoshiaki Nishio; Masaru Takeuchi
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.